DK1254209T3 - Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab - Google Patents

Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab

Info

Publication number
DK1254209T3
DK1254209T3 DK01977759T DK01977759T DK1254209T3 DK 1254209 T3 DK1254209 T3 DK 1254209T3 DK 01977759 T DK01977759 T DK 01977759T DK 01977759 T DK01977759 T DK 01977759T DK 1254209 T3 DK1254209 T3 DK 1254209T3
Authority
DK
Denmark
Prior art keywords
garcinol
anthocyanin
composition
hca
reduction
Prior art date
Application number
DK01977759T
Other languages
English (en)
Inventor
Muhammed Majeed
Vladimir Badmaev
Original Assignee
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sabinsa Corp filed Critical Sabinsa Corp
Application granted granted Critical
Publication of DK1254209T3 publication Critical patent/DK1254209T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
DK01977759T 2000-08-17 2001-08-17 Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab DK1254209T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22582100P 2000-08-17 2000-08-17

Publications (1)

Publication Number Publication Date
DK1254209T3 true DK1254209T3 (da) 2006-07-24

Family

ID=22846386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01977759T DK1254209T3 (da) 2000-08-17 2001-08-17 Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab

Country Status (12)

Country Link
US (1) US7063861B2 (da)
EP (1) EP1254209B1 (da)
JP (2) JP4205943B2 (da)
AT (1) ATE320248T1 (da)
AU (1) AU773081B2 (da)
CA (1) CA2387548A1 (da)
DE (1) DE60118019T2 (da)
DK (1) DK1254209T3 (da)
ES (1) ES2260293T3 (da)
NZ (1) NZ518116A (da)
PT (1) PT1254209E (da)
WO (1) WO2002014477A2 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1254209T3 (da) * 2000-08-17 2006-07-24 Sabinsa Corp Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab
US20030187055A1 (en) * 2002-02-25 2003-10-02 Riker Donald K. Synergistic pharmaceutical combinations for treating obesity
WO2003092730A1 (en) * 2002-04-30 2003-11-13 Unibar Corporation Hydroxycitric acid salt composition and method of making
US8394856B2 (en) * 2002-07-02 2013-03-12 Glykon Technologies Group, Llc (-)-Hydroxycitric acid for controlling inflammation
CA2527133A1 (en) * 2003-05-29 2004-12-09 Glykon Technologies Group, Llc Method and composition for stable and controlled delivery of (-)-hydroxycitric acid
WO2005007088A2 (en) * 2003-07-03 2005-01-27 Unibar Corporation Stabilized anthocyanin extract from garcinia indica
US20050009919A1 (en) * 2003-07-07 2005-01-13 Clouatre Dallas L. Treating cachexia and excessive catabolism with (-)-hydroxycitric acid
US20080207952A1 (en) * 2003-10-09 2008-08-28 Muhammed Majeed Novel therapeutic applications of natural poly isoprenylated benzophenone derivatives as drugs/medicaments
US7386111B2 (en) * 2004-02-10 2008-06-10 Vonage Network Inc. Method and apparatus for placing a long distance call based on a virtual phone number
EP1781116A4 (en) 2004-06-04 2009-07-29 Horizon Science Pty Ltd NATURAL SWEETENER
JP5775656B2 (ja) 2005-06-03 2015-09-09 ホリズン サイエンス ピーティーワイ リミテッド ボディマス再分布性を有する物質
JP2010503417A (ja) 2006-09-19 2010-02-04 ホリズン サイエンス ピーティーワイ リミテッド サトウキビに由来する抽出物、およびこれらの製造方法
WO2008049121A2 (en) * 2006-10-19 2008-04-24 Renaissance Herbs, Inc. Hydroxycitric acid compositions, methods of making, and therapeutic uses of same
US20100166851A1 (en) * 2007-05-04 2010-07-01 Nutraceutic Et Business Consulting Composition having lipolytic activity, production method thereof and use of the composition
JP5117762B2 (ja) * 2007-05-18 2013-01-16 株式会社半導体エネルギー研究所 液晶表示装置
US20090062231A1 (en) * 2007-08-31 2009-03-05 O'mara Ann Marie Appetite Suppressant Composition and Method of Appetite Suppression
US20100233306A1 (en) * 2009-03-16 2010-09-16 Sevanti Mehta Methods and compositions for weight loss using garcinia indica fruit puree
AU2011352073B2 (en) * 2010-12-30 2015-12-24 Sami Labs Limited Hepatoprotectant activity of garcinol
US8329743B2 (en) * 2011-01-10 2012-12-11 Sami Labs Limited Compositions and its use in treating obesity or inducing weight loss
CN103561585B (zh) 2011-02-08 2016-05-25 产品制造者(澳大利亚)有限公司 糖提取物
AU2013308395C1 (en) 2012-08-28 2018-03-15 Poly Gain Pte Ltd Extraction method
AU2014306366B9 (en) 2013-08-16 2020-03-26 Poly Gain Pte Ltd Sugar cane derived extracts and methods of treatment
US10285961B2 (en) 2014-02-06 2019-05-14 University Of Houston System Organic acids as agents to dissolve calcium minerals in pathological calcification and uses thereof
KR101781365B1 (ko) * 2016-08-31 2017-09-25 주식회사 코씨드바이오팜 반응표면분석법을 이용하여 가르시니아 캄보지아로부터 하이드록시 시트르산을 고수율로 추출하는 방법
BR112019026824A2 (pt) * 2017-06-15 2020-06-30 Sami Labs Limited potencial antiobesidade de garcinol
WO2019212929A1 (en) * 2018-04-30 2019-11-07 Muhammed Majeed Compositions for weight loss
GB2623571A (en) * 2022-10-21 2024-04-24 Mootral Innovations Ltd Compositions for reducing methane emission

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276253B1 (it) * 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
DK0815857T3 (da) * 1995-12-26 2005-01-24 Suntory Ltd Anti-adipöst middel indeholdende procyanidin som den aktive ingrediens
JPH10203968A (ja) * 1997-01-27 1998-08-04 Munekazu Iinuma 抗腫瘍剤
JPH10265397A (ja) * 1997-03-25 1998-10-06 Toyotama Kenko Shokuhin Kk 肥満予防剤
JPH111431A (ja) * 1997-06-10 1999-01-06 Nichiyaku Kk 肥満抑制剤
JPH11139965A (ja) * 1997-11-06 1999-05-25 Kikkoman Corp 抗腫瘍薬
JP2000044468A (ja) * 1998-07-29 2000-02-15 Kikkoman Corp リパーゼ阻害剤及び抗肥満剤又は高脂血症抑制剤
JP2000072665A (ja) * 1998-08-31 2000-03-07 Kikkoman Corp ヒアルロニダーゼ阻害剤
WO2000012080A1 (en) 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management
FR2790645B1 (fr) * 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
JP2000355536A (ja) * 1999-06-10 2000-12-26 Kikkoman Corp 発癌予防薬
FR2804319B1 (fr) * 2000-01-28 2002-10-25 Clarins Lab Composition cosmetique amincissante comprenant en tant qu'agent actif un extrait de plante contenant de l'anp
DK1254209T3 (da) * 2000-08-17 2006-07-24 Sabinsa Corp Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab

Also Published As

Publication number Publication date
JP2004506657A (ja) 2004-03-04
WO2002014477A2 (en) 2002-02-21
ATE320248T1 (de) 2006-04-15
PT1254209E (pt) 2006-08-31
JP4205943B2 (ja) 2009-01-07
JP2008110996A (ja) 2008-05-15
CA2387548A1 (en) 2002-02-21
NZ518116A (en) 2005-06-24
ES2260293T3 (es) 2006-11-01
EP1254209B1 (en) 2006-03-15
DE60118019D1 (de) 2006-05-11
EP1254209A4 (en) 2004-09-08
AU773081B2 (en) 2004-05-13
WO2002014477A3 (en) 2002-08-01
US20020187943A1 (en) 2002-12-12
US7063861B2 (en) 2006-06-20
EP1254209A2 (en) 2002-11-06
DE60118019T2 (de) 2006-11-02
AU9685101A (en) 2002-02-25

Similar Documents

Publication Publication Date Title
DK1254209T3 (da) Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab
DE60209504D1 (de) Carbocyclische hydrazino-hemmer von kupferhaltigen aminoxidasen
TW200633695A (en) Methods for purifying trans-(-)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol
BR0317149A (pt) Métodos para uso de uma composição para bebidas
CY1105930T1 (el) Χρηση αναστολεων c-kit για θepαπεια ασθενειων φλεγμονωδους εντερου (ibd)
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
DE60230961D1 (de) Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung
ATE198467T1 (de) Diaromatische propynyl- oder dienylverbindungen
BR0008865A (pt) Composições contendo fluoreto estanhoso para o tratamento de dentes hipersensìveis
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
HK1073228A1 (en) Aromatic herb preparation
TW200501973A (en) Method of improvement of blood circulation
RU2673075C1 (ru) Защитный крем для участков кожи с ограниченным воздухообменом